Skip to search formSkip to main contentSkip to account menu

PELF protocol

Known as: PELF Regimen, Platinol-Epirubicin-Leucovorin-Fluorouracil Regimen 
A regimen consisting of cisplatin, epirubicin, leucovorin and fluorouracil used for the treatment of advanced-stage gastric cancer. This regimen… 
National Institutes of Health

Related topics

Related topics

6 relations
CisplatinEpirubicin HydrochlorideFLEP protocolFluorouracil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
[Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer].
OBJECTIVE To investigate the efficiency, time to progression (TTP), overall survival (OS) and toxicity of epirubicin combined… 
2006
2006
HtrA1 expression as a predictive factor of response to cisplatin-based regimen in patients with advanced gastric cancer.
4077 Background: Human HtrA1 is a member of the HtrA (High temperature requirement) family of serine proteases. Recent reports… 
2003
2003
Treatment of Advanced Gastric Cancer: Where We Are in 2003
The issue of the effectiveness of systemic chemotherapy in metastatic gastric carcinoma engendered considerable debate during the… 
1996
1996
136 P - Feasibility and activity of a 3-day pelf-like regimen in advanced gastric cancer. Preliminary data
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)